Emily Hill
2021
In 2021, Emily Hill earned a total compensation of $4.5M as Chief Financial Officer at PTC Therapeutics, a 22% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $312,100 |
|---|---|
| Option Awards | $2,954,700 |
| Salary | $489,500 |
| Stock Awards | $718,092 |
| Other | $12,740 |
| Total | $4,487,132 |
Hill received $3M in option awards, accounting for 66% of the total pay in 2021.
Hill also received $312.1K in non-equity incentive plan, $489.5K in salary, $718.1K in stock awards and $12.7K in other compensation.
Rankings
In 2021, Emily Hill's compensation ranked 2,955th out of 12,415 executives tracked by ExecPay. In other words, Hill earned more than 76.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,955 out of 12,415 | 76th |
Division Manufacturing | 1,182 out of 5,505 | 79th |
Major group Chemicals And Allied Products | 477 out of 2,375 | 80th |
Industry group Drugs | 420 out of 2,096 | 80th |
Industry Pharmaceutical Preparations | 286 out of 1,546 | 82nd |
Source: SEC filing on April 28, 2022.
Hill's colleagues
We found four more compensation records of executives who worked with Emily Hill at PTC Therapeutics in 2021.